Olfactory recovery following infection with COVID-19: A systematic review

Olfactory loss has been identified as one of the common symptoms related to COVID-19 infection. Although olfactory loss is recognized, our understanding of both the extent of loss and time to olfactory recovery following infection is less well known. Similarly, knowledge of potential impactful patie...

Full description

Bibliographic Details
Main Authors: Ali Jafar, Andrea Lasso, Risa Shorr, Brian Hutton, Shaun Kilty
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577770/?tool=EBI
_version_ 1818856508190883840
author Ali Jafar
Andrea Lasso
Risa Shorr
Brian Hutton
Shaun Kilty
author_facet Ali Jafar
Andrea Lasso
Risa Shorr
Brian Hutton
Shaun Kilty
author_sort Ali Jafar
collection DOAJ
description Olfactory loss has been identified as one of the common symptoms related to COVID-19 infection. Although olfactory loss is recognized, our understanding of both the extent of loss and time to olfactory recovery following infection is less well known. Similarly, knowledge of potential impactful patient factors and therapies that influence olfactory recovery is desirable but is not overtly clear in the literature. Our systematic review sought to fill this knowledge gap. We included studies that: involved either an observational or an interventional design that reported data on patients with olfactory dysfunction due to Reverse Transcription Polymerase Chain Reaction (RT-PCR) diagnosed COVID-19 infection; and reported data regarding olfactory recovery measured by an objective olfactory test, Likert scale and/or visual analog scale (VAS). The study methods were determined a priori and registered in PROSPERO (Registration Number CRD42020204354). An information specialist searched Medline, Embase, LitCovid and the Cochrane Register of Controlled Trials up to March 2021, and two reviewers were involved in all aspects of study selection and data collection. After screening 2788 citations, a total of 44 studies of assorted observational designs were included. Patients had undergone objective COVID-19 testing, and most were adult patients with mild to moderate COVID-19. Olfactory recovery was found to occur as early as 7 days, with most patients recovering olfaction within 30 days. Few studies included prolonged follow-up to 6 months or longer duration. Poor olfaction at initial presentation was associated with poor recovery rates. Only a small number of studies assessed olfactory retraining and steroid therapy. Additional trials are underway.
first_indexed 2024-12-19T08:25:37Z
format Article
id doaj.art-c6c88b782c32455f80fa70f68d3438f2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T08:25:37Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c6c88b782c32455f80fa70f68d3438f22022-12-21T20:29:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-011611Olfactory recovery following infection with COVID-19: A systematic reviewAli JafarAndrea LassoRisa ShorrBrian HuttonShaun KiltyOlfactory loss has been identified as one of the common symptoms related to COVID-19 infection. Although olfactory loss is recognized, our understanding of both the extent of loss and time to olfactory recovery following infection is less well known. Similarly, knowledge of potential impactful patient factors and therapies that influence olfactory recovery is desirable but is not overtly clear in the literature. Our systematic review sought to fill this knowledge gap. We included studies that: involved either an observational or an interventional design that reported data on patients with olfactory dysfunction due to Reverse Transcription Polymerase Chain Reaction (RT-PCR) diagnosed COVID-19 infection; and reported data regarding olfactory recovery measured by an objective olfactory test, Likert scale and/or visual analog scale (VAS). The study methods were determined a priori and registered in PROSPERO (Registration Number CRD42020204354). An information specialist searched Medline, Embase, LitCovid and the Cochrane Register of Controlled Trials up to March 2021, and two reviewers were involved in all aspects of study selection and data collection. After screening 2788 citations, a total of 44 studies of assorted observational designs were included. Patients had undergone objective COVID-19 testing, and most were adult patients with mild to moderate COVID-19. Olfactory recovery was found to occur as early as 7 days, with most patients recovering olfaction within 30 days. Few studies included prolonged follow-up to 6 months or longer duration. Poor olfaction at initial presentation was associated with poor recovery rates. Only a small number of studies assessed olfactory retraining and steroid therapy. Additional trials are underway.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577770/?tool=EBI
spellingShingle Ali Jafar
Andrea Lasso
Risa Shorr
Brian Hutton
Shaun Kilty
Olfactory recovery following infection with COVID-19: A systematic review
PLoS ONE
title Olfactory recovery following infection with COVID-19: A systematic review
title_full Olfactory recovery following infection with COVID-19: A systematic review
title_fullStr Olfactory recovery following infection with COVID-19: A systematic review
title_full_unstemmed Olfactory recovery following infection with COVID-19: A systematic review
title_short Olfactory recovery following infection with COVID-19: A systematic review
title_sort olfactory recovery following infection with covid 19 a systematic review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577770/?tool=EBI
work_keys_str_mv AT alijafar olfactoryrecoveryfollowinginfectionwithcovid19asystematicreview
AT andrealasso olfactoryrecoveryfollowinginfectionwithcovid19asystematicreview
AT risashorr olfactoryrecoveryfollowinginfectionwithcovid19asystematicreview
AT brianhutton olfactoryrecoveryfollowinginfectionwithcovid19asystematicreview
AT shaunkilty olfactoryrecoveryfollowinginfectionwithcovid19asystematicreview